ACM
TCRT icon

Allred Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Allred Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,687
Closed -$11.8K – 177
2024
Q2 		$11.8K Hold
1,687
– – ﹤0.01% 170
2024
Q1 		$30.5K Hold
1,687
– – 0.01% 170
2023
Q4 		$17.9K Hold
1,687
– – 0.01% 166
2023
Q3 		$33.3K Hold
1,687
– – 0.02% 152
2023
Q2 		$129K Buy
1,687
+334
+25% +$27K 0.06% 157
2023
Q1 		$128K Buy
1,353
+66
+5% +$6.28K 0.07% 154
2022
Q4 		$125K Buy
1,287
+234
+22% +$33.9K 0.07% 149
2022
Q3 		$271K Buy
1,053
+33
+3% +$9.59K 0.17% 120
2022
Q2 		$189K Buy
1,020
+167
+20% +$16K 0.12% 151
2022
Q1 		$83K Buy
853
+166
+24% +$21.3K 0.04% 166
2021
Q4 		$112K Buy
687
+334
+95% +$73.4K 0.05% 181
2021
Q3 		$96K Buy
353
+140
+66% +$42.8K 0.05% 175
2021
Q2 		$84K Buy
213
+33
+18% +$15.4K 0.04% 181
2021
Q1 		$97.2K Hold
180
– – 0.04% 266
2020
Q4 		$68K Sell
180
-15
-8% -$5.96K 0.04% 170
2020
Q3 		$73K Buy
195
+33
+20% +$14.6K 0.04% 160
2020
Q2 		$79K Sell
162
-26
-14% -$11.6K 0.05% 158
2020
Q1 		$69K Buy
188
+28
+18% +$14.5K 0.05% 133
2019
Q4 		$113K Buy
160
+17
+12% +$11.7K 0.06% 199
2019
Q3 		$88K Hold
143
– – 0.05% 160
2019
Q2 		$116K Hold
143
– – 0.07% 174
2019
Q1 		$86K Hold
143
– – 0.05% 183
2018
Q4 		$40K Buy
+143
New +$56.5K 0.03% 171

Other funds holding TCRT

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Allred Capital Management's TCRT Position: Q3 2024 in Review

Allred Capital Management sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 1,687 shares — an estimated $11.8K sold.

Allred Capital Management first reported a position in TCRT in Q4 2018 and held it in 23 quarters. The position peaked at $271K in Q3 2022. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Allred Capital Management reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Allred Capital Management sold 1,687 Alaunos Therapeutics shares in Q3 2024, an estimated $11.8K.
  • Allred Capital Management first reported a position in Alaunos Therapeutics in Q4 2018 and held it in 23 quarters.
  • Allred Capital Management's Alaunos Therapeutics position peaked at $271K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Allred Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.